Lisata Therapeutics (LTS:0HS8) Accounts Payable : $1.28 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Lisata Therapeutics Accounts Payable?

Lisata Therapeutics's Accounts Payable for the quarter that ended in Dec. 2024 was $1.28 Mil.

Lisata Therapeutics's quarterly Accounts Payable declined from Jun. 2024 ($0.73 Mil) to Sep. 2024 ($0.56 Mil) but then increased from Sep. 2024 ($0.56 Mil) to Dec. 2024 ($1.28 Mil).

Lisata Therapeutics's annual Accounts Payable declined from Dec. 2022 ($2.66 Mil) to Dec. 2023 ($2.42 Mil) and declined from Dec. 2023 ($2.42 Mil) to Dec. 2024 ($1.28 Mil).

Lisata Therapeutics Accounts Payable Historical Data

The historical data trend for Lisata Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lisata Therapeutics Accounts Payable Chart

Lisata Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable

Get a 7-Day Free Trial

1.02

1.93

2.66

2.42

1.28

Lisata Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Accounts Payable	Get a 7-Day Free Trial															2.42	1.26	0.73	0.56	1.28

Lisata Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Lisata Therapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Lisata Therapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Lisata Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lisata Therapeutics Inc (LTS:0HS8) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

LSTA:USA

Address

110 Allen Road, 2nd Floor, Basking Ridge, NJ, USA, 07920

Website

https://www.lisata.com

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Lisata Therapeutics Headlines

No Headlines